Cardiovascular disease risk factors among transgender women in Chiang Mai, Thailand

Transgender individuals take hormone therapy (HT) for transitioning secondary sexual characteristics, especially by transgender women assigned male at birth (AMAB). The transgender drug is a relatively new field in health care, but limited data exist to inform the cardiovascular risk factor profile...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Cardiovasc Dis
Asıl Yazarlar: Kulprachakarn, Kanokwan, Ounjaijean, Sakaewan, Rerkasem, Kittipan, Molinsky, Rebecca L, Demmer, Ryan T
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364281/
https://ncbi.nlm.nih.gov/pubmed/32685270
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller